阿托瓦斯塔丁与主观记忆缺陷的相关性:来自NHANES和FAERS数据库的研究
Hao Zhang1, Hua Huang1, Panli Zhao1
1Department of Pharmacy, Chengdu Seventh People's Hospital (Affiliated Tumor Hospital of Chengdu Medical College), Chengdu, China.
Frontiers in neurology
|March 25, 2025
概括
根据NHANES数据,阿托瓦斯塔丁可能会降低记忆丧失风险. 然而,正如FAERS数据所示,一些患者报告阿托瓦斯塔丁的记忆问题,需要仔细考虑风险和益处.
科学领域:
- 药物监督 药物监督 药物监督
- 临床药理学 临床药理学
- 神经学 神经学
背景情况:
- 营销后的数据表明,阿托瓦斯塔丁可能会保护记忆,但观察性研究显示了相互矛盾的结果.
- 不一致的发现凸显了对阿托瓦斯塔丁对记忆的影响进一步调查的必要性.
研究的目的:
- 调查阿托瓦斯塔丁暴露与主观记忆缺陷之间的相关性.
- 为阿托瓦斯塔丁临床使用提供关于记忆功能的准确安全性和疗效信息.
主要方法:
- 使用了国家健康和营养检查调查 (NHANES) 和食品和药物管理局不良事件报告系统 (FAERS) 数据.
- 使用描述性统计,多变量逻辑回归和接收器操作特征 (ROC) 曲线来分析阿托瓦斯塔丁暴露和记忆功能.
主要成果:
- 根据NHANES分析,阿托瓦斯塔丁使用与记忆丧失风险降低有关 (OR=0.47;p=0.004).
- 在15277份与阿托瓦斯塔丁相关的报告中,FAERS数据揭示了包括记忆丧失在内的401个精神病不良事件.
- 研究结果表明,阿托瓦斯塔丁可能不会普遍增加记忆丧失风险,但可能会出现个别副作用.
结论:
- 综合的NHANES和FAERS数据提供了阿托瓦斯塔丁与记忆的关系的全面视图.
- NHANES数据支持潜在的记忆益处,而FAERS数据强调潜在的认知副作用.
- 临床医生和患者必须权衡阿托瓦斯塔丁的益处与风险,考虑个体差异和监测策略.
相关概念视频
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:23Assessment of the Cardiovascular System I: Subjective Data
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...